Tiziana Life Sciences
TLSA
24 hedge funds and large institutions have $3.97M invested in Tiziana Life Sciences in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
4% more funds holding
Funds holding: 23 → 24 (+1)
0.67% less ownership
Funds ownership: 5.88% → 5.21% (-0.67%)
34% less capital invested
Capital invested by funds: $6.02M → $3.97M (-$2.05M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$48.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$30.6K |
| 3 |
ZF
Zhang Financial
Portage,
Michigan
|
+$16.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.92K |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$212K |
| 2 |
HSBC Holdings
London,
United Kingdom
|
-$121K |
| 3 |
JP Morgan Chase
New York
|
-$91K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$30K |
| 5 |
VF
Virtu Financial
New York
|
-$16.1K |
TLSA Hedge Fund Activity: Q2 2022 in Review
24 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2022, worth a combined $3.97M — down 34% from $6.02M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TLSA positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $48.2K. The largest seller was Citigroup, cutting an estimated $212K.
- 24 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2022, up from 23 in Q1 2022.
- Funds reported $3.97M of Tiziana Life Sciences stock for Q2 2022, down 34% quarter-over-quarter.
- 3 funds opened new Tiziana Life Sciences positions in Q2 2022 and 2 closed out, a net change of +1 holder.
- The largest Tiziana Life Sciences buyer in Q2 2022 was Morgan Stanley, an estimated $48.2K added.
- The largest Tiziana Life Sciences seller in Q2 2022 was Citigroup, an estimated $212K sold.
Based on aggregated 13F filings for Q2 2022.